|
OSBPL8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.609300E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.193620E-04 |
| Normal-vs-Stage2 |
5.723800E-03 |
| Normal-vs-Stage3 |
7.382400E-02 |
| Normal-vs-Stage4 |
1.355380E-01 |
| Stage1-vs-Stage2 |
6.865600E-01 |
| Stage1-vs-Stage3 |
1.212580E-01 |
| Stage1-vs-Stage4 |
3.782800E-01 |
| Stage2-vs-Stage3 |
4.130600E-01 |
| Stage2-vs-Stage4 |
5.969200E-01 |
| Stage3-vs-Stage4 |
9.137600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.796500E-04 |
| Normal-vs-AfricanAmerican |
6.970200E-04 |
| Normal-vs-Asian |
3.563700E-02 |
| Caucasian-vs-AfricanAmerican |
9.932800E-01 |
| Caucasian-vs-Asian |
8.275000E-01 |
| AfricanAmerican-vs-Asian |
7.966000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.49410000002981E-06 |
| Normal-vs-Female |
1.157210E-01 |
| Male-vs-Female |
3.645000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.623600E-04 |
| Normal-vs-Extreme_Weight |
4.38589999984806E-07 |
| Normal-vs-Obese |
1.355730E-02 |
| Normal-vs-Extreme_Obese |
1.205870E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.966400E-01 |
| Normal_Weight-vs-Obese |
2.949600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.032600E-01 |
| Extreme_Weight-vs-Obese |
1.493890E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.305400E-01 |
| Obese-vs-Extreme_Obese |
6.057400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.877800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.015710E-02 |
| Normal-vs-Age(61-80Yrs) |
1.98578999999199E-05 |
| Normal-vs-Age(81-100Yrs) |
7.581000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.668200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.892310E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.093790E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.863770E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.289600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.354000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.38990000000139E-05 |
| Normal-VS-Type2 PRCC |
2.037100E-03 |
| Normal-VS-KIRP CIMP |
4.742600E-01 |
| Normal-VS-Unclassified PRCC |
3.292600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.958000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.018970E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.602400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.313800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.743160E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.272800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.590400E-04 |
| Normal-vs-N1 |
4.566400E-01 |
| Normal-vs-N2 |
3.420400E-02 |
| N0-vs-N1 |
2.821700E-02 |
| N0-vs-N2 |
8.171200E-01 |
| N1-vs-N2 |
2.576600E-01 |
|
|
